Sleep attacks in Parkinson's disease induced by Entacapone, a COMT-inhibitor

Fundamental and Clinical Pharmacology

Volumn 17, Issue 1, 2003, Pages 121-123

  Santens, Patrick ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Entacapone; Parkinson's disease; Sleep attacks

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; ENTACAPONE; LEVODOPA;

AGED; ARTICLE; CASE REPORT; CIRCADIAN RHYTHM; ENZYME INHIBITION; HUMAN; MALE; NIGHT SLEEP; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; REM SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; WAKEFULNESS;

AGED; ANTIPARKINSON AGENTS; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; MALE; PARKINSON DISEASE; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 0037326314     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00121.x     Document Type: Article

References (23)

1. Frucht S.J., Rogers J.D., Greene P.E., Gordon M.F., Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology (1999) 52 1908-1910.
2. Ferreira J.J., Galitzky M., Montastruc J.L., Rascol O. Sleep attacks and Parkinson's disease treatment. Lancet (2000) 355 1333-1334.
3. Schafer D., Greulich W. Effects of parkinsonian medication on sleep. J. Neurol. (2000) 247 (Suppl. 4) 24-27.
4. Olanow C.W., Schapira A.H.V., Roth T. Waking up to sleep episodes in Parkinson's disease. Mov. Disord. (2000) 15 212-215.
5. Larsen J.P., Tandberg E. Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs (2001) 15 267-275.
6. Ferreira J.J., Thalamas C., Montastruc J.L., Castro-Caldas A., Rascol O. Levodopa monotherapy can induce 'sleep attacks' in Parkinson's disease patients. J. Neurol. (2001) 248 426-427.
7. Montastruc J.L., Brefel-Courbon C., Senard J.M. et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin. Neuropharmacol. (2001) 24 181-183.
8. Clarenbach P. Parkinson's disease and sleep. J. Neurol. (2000) 247 (Suppl 4). 20-23.
9. Frucht S.J., Greene P.E., Fahn S. Sleep episodes in Parkinson's disease: a wake-up call. Mov. Disord. (2000) 15 601-603.
10. Tracik F., Ebersach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. Mov. Disord. (2001) 16 500-506.
11. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. (1981). 30 239-245.
12. Rinne U.K., Larsen J.P., Siden A., Worm-Petersen J., Nomecomt study group. Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Neurology (1998) 51 1309-1314.
13. Parkinson Study group. Entacapone improves motor fluctuations in levodopa-treated parkinson's disease patients. Ann. Neurol. (1997) 42 747-755.
14. Ryan M., Slevin J.T., Wells A. Non-ergot dopamine agonist-induced sleep attacks. Pharmacotherapy (2000) 20 724-726.
15. Etminan M., Samii A., Takkouche B., Rochon Pa. Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials. Drug Saf. (2001) 24 863-868.
16. Hauser R.A., Gauger L., Zesiewicz T.A. Pramipexole-induced somnolence and episodes of daytime sleep. Mov. Disord. (2000) 15 658-663.
17. Tandberg E., Larsen J.P., Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord (1999) 14 922-927.
18. Ondo W.G., Dat Vuong K., Khan H., Atassi F., Kwak C., Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology (2001) 57 1392-1396.
19. Pal S., Bhattacharya K.F., Agapito C., Chaudhuri K.R. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J. Neural. Transm. (2001) 108 71-77.
20. Schapira A.H.V. Sleep attacks with pergolide. Lancet (2000) 355 1332-1333.
21. Clarenbach P., Greulich W., Meinck H.M. et al. Workshop I: Parkinson's disease and sleep - results of the group discussion. J. Neurol. (2000) 247 (Suppl. 4) 34-35.
22. Pirker W., Happe S. Sleep attacks in Parkinson's disease. Lancet (2000) 356 597-598.
23. Nutt J.G. Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients. Neurology (2000) 55 (Suppl. 4) S33-S37.